Idicula M.

Idicula M. has a wealth of experience in the medical and technology industries. Idicula has held several positions since 2011, including Bioengineering Researcher at the University of North Texas (TAMS), Innovations & Ecosystem Analyst at AT&T, CTO & Co-Founder at CrossX (Acquired), Procurement/ Innovation Engineer at GE, Biomedical Engineering Researcher and Resident Advisor (Peer Leader) at the Georgia Institute of Technology, and, most recently, CEO and Co-Founder at Hera Health Solutions. At Hera Health Solutions, Idicula M. is developing the world's first biodegradable drug delivery platform for long-acting therapeutics. Additionally, they are an EIR, Startup Mentor at Tufts University.

Idicula M. has completed educational programs at the Georgia Institute of Technology, the University of Galway, and the Texas Academy of Mathematics and Science. At Georgia Institute of Technology, they studied Bioengineering and Biomedical Engineering. Through the Georgia Tech Faculty-Led Study Abroad Program, Idicula M. studied Biomedical Engineering at the University of Galway. Lastly, they completed the TAMS Program at the Texas Academy of Mathematics and Science.